iBiopublic
iBio, Inc. is a biotech company. The Company develops next-generation biopharmaceuticals for cardiometabolic, obesity, cancer and other hard-to-treat diseases through AI and advanced computational biology. iBio operates in the United States.
Funding
Every round, secondary, debt facility or acquisition involving iBio that AI Lounge tracks, newest first.
No rounds recorded yet.
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in